THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

NCT02002325 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Tissue-type plasminogen activator (alteplase)
OTHER: Standard care

Sponsor

National Cerebral and Cardiovascular Center, Japan

Collaborators

[object Object]
[object Object]